Ian M Bouligny

14PUBLICATIONS
59CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene and molecular therapyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 26, 2026
Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia.

|Jan 26, 2026
Incorporation of Genomic Determinants Improves Diagnostic Accuracy of Oligomonocytic Chronic Myelomonocytic Leukemia.

Guillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla

|Jul 21, 2025
Erythroid-predominant myelodysplastic neoplasms exhibit a distinct genomic landscape with poor outcomes after venetoclax-based therapy.

Alexandre Bazinet, Sanam Loghavi, Yue Wei

|May 09, 2025
Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangements.

Alex Bataller, Hannah E Goulart, Ghayas C Issa

|Mar 18, 2025
A retrospective study of outcomes across time and treatment regimens in newly diagnosed, FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukemia.

Alexandre Bazinet, Alex Bataller, Tapan Kadia

|Feb 23, 2024
Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia.

Ian M Bouligny, Graeme Murray, Michael Doyel

Pageof 3

Frequent Collaborators

9 joint publications

Tapan M Kadia

8 joint publications

Farhad Ravandi

8 joint publications

Naval G Daver

8 joint publications

Courtney DiNardo